![Volker Pfahlert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Volker Pfahlert
Director/Board Member at numares AG
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Maria Severina | M | - |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | 30 years |
Christiane Proll | F | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Nicolas Roelofs | M | 66 |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | - |
Jon Hindar | M | 68 |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | - |
Gerhard Ries | M | 55 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Kathy L. Bates | F | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 5 years |
Bernhard Schirmers | M | 70 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Gregory F. Heath | M | 66 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 2 years |
Claus Botzler | M | 59 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Tommi Markus Unkuri | M | 44 |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | - |
Philipp Pagel | M | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 13 years |
Rainer Kutzner | M | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Johan Pietilä Holmner | M | - |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | - |
Fred S. Apple | M | - |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | 8 years |
Nick Roelofs | M | - |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Maximilian Zucker | M | 53 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 4 years |
Winton G. Gibbons | M | 61 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 3 years |
Hans-Henning Doerr | M | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Gerd Grenner | M | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 5 years |
Rainer Sturm | M | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 5 years |
Titus Kaletta | M | 55 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 14 | 66.67% |
Finland | 7 | 33.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Volker Pfahlert
- Personal Network